hotspot -WSS

hotspot

author：Wikipedia 2025-09-29 22:53:01 - browse：92165

portrait of Jennifer Adair -- coverage from STAT — Jennifer Adair develops scalable, low cost gene therapies at the Fred Hutchinson Cancer Center and helped found the Global Gene Therapy Initiative. Fred Hutch News Service

BALTIMORE — Gene and cell therapies have transformed a handful of devastating disorders in the U.S. and Europe, with more treatments on the way. But those technologies have largely failed to reach most of the world.

These lags are ubiquitous in the current drug development system, where new therapies are approved in wealthy countries and then slowly leak out to low- and middle-income countries, many years later. In the case of gene therapy, that means countries most affected by a disease such as sickle cell may wait decades to access a curative therapy.

For the last few years, a handful of researchers in the U.S. and around the world have tried to find ways of ensuring global access to these technologies. In 2020, they formed the Global Gene Therapy Initiative, with an initial goal of setting up a gene therapy clinical trial for a hemoglobinopathy — such as a disease like sickle cell or beta thalassemia — or HIV in two different low- and middle-income countries by 2024.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Johnson & Johnson sues to stop Medicare negotiation

leisure time

WSS

In medicine, common shorthands can shortchange care

Nearly a dozen Russian and Chinese ships now moving away from Alaska, officials say

Israeli protesters block highways, train stations as Netanyahu moves ahead with judicial overhaul

Nearly a dozen Russian and Chinese ships now moving away from Alaska, officials say

Ford plant in Missouri shuts down over 'possible threat,' sheriff's office says

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

hotspot

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

Cancer drug shortages should be causing more outrage

Prince Harry and Meghan to work on film adaptation of 'Meet Me at the Lake' novel

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Search resumes for 2 missing children washed away with mom in deadly Pennsylvania flash flood

Drug repurposing or repositioning? The language matters

DeSantis and Newsom agree to Sean Hannity debate, then disagree on the rules

BioMarin wins approval for gene therapy to treat hemophilia A

The UK government moves asylum

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

At least 12 people were injured in a blast at a port in northwest Turkey

explore

Mississippi candidates for statewide offices square off in party primaries

Bursting ice dam in Alaska highlights risks of glacial flooding around the globe

Teen said 'homophobic slurs' before O'Shae Sibley killing: Criminal complaint

What we know about the American soldier detained in North Korea

Trump Jan. 6 attorney John Lauro is ex

South Korea begins evacuating thousands of Scouts from coastal campsite as tropical storm nears

hotspot

entertainment

leisure time

leisure time